Literature DB >> 36002584

Evaluating the time-varying risk of hypertension, cardiac events, and mortality following Kawasaki disease diagnosis.

Jennifer J Y Lee1,2,3, Brian M Feldman4,5,6, Brian W McCrindle4,5, Ping Li7, Rae Sm Yeung4,5, Jessica Widdifield7,5,6,8.   

Abstract

BACKGROUND: This study evaluated the risk of hypertension, major adverse cardiac events (MACE), and all-cause mortality in Kawasaki disease (KD) patients up to young adulthood.
METHODS: An inception cohort of 1169 KD patients between 1991 and 2008 from a tertiary-level hospital in Ontario, Canada was linked with health administrative data to ascertain outcomes up to 28 years of follow-up. Their risk was compared with 11,690 matched population comparators. The primary outcome was hypertension and secondary outcomes were MACE and death.
RESULTS: After a median follow-up of 20 years [IQR: 8.3], the cumulative incidence of hypertension and MACE in the KD group was 3.8% (95% CI: 2.5-5.5) and 1.2% (95% CI: 0.6-2.4%), respectively. The overall survival probability in the KD group was 98.6% (95% CI: 97.2-99.3%). Relative to comparators, KD patients were at an increased risk for hypertension [aHR: 2.2 (95% CI: 1.5-3.4)], death [aHR: 2.5 (95% CI: 1.3-5.0)], and MACE [aHR: 10.7 (95% CI: 6.4-17.9)]. For hypertension and MACE, the aHR was the highest following diagnosis and then the excess risk diminished after 16 and 13 years of follow-up, respectively. MACE occurred largely in KD patients with coronary aneurysms [cumulative incidence: 12.8%].
CONCLUSIONS: KD patients demonstrated a reassuring cardiac prognosis up to young adulthood with low events and excellent survival. KD patients were at increased risk for hypertension, but this excess risk occurred early and declined with time. IMPACT: With the current standard of care, KD patients demonstrated favorable cardiac prognosis, with low events of hypertension, MACE, and excellent survival. Hypertension and MACE risk appear to be highest around the time of KD diagnosis. MACE occurred primarily in KD patients with coronary aneurysms. Our findings are reassuring to KD patients, families, and their providers. Our study demonstrated an association between KD exposure and hypertension. This association is relatively novel. Previous studies have remained conflicting if KD contributes to long-term atherosclerotic risk.
© 2022. The Author(s), under exclusive licence to the International Pediatric Research Foundation, Inc.

Entities:  

Year:  2022        PMID: 36002584     DOI: 10.1038/s41390-022-02273-8

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.953


  55 in total

1.  Prevalence of Kawasaki disease in young adults with suspected myocardial ischemia.

Authors:  Lori B Daniels; Matthew S Tjajadi; Hannah H Walford; Susan Jimenez-Fernandez; Vera Trofimenko; Daryl B Fick; Hoang-Anh L Phan; Peter E Linz; Keshav Nayak; Andrew M Kahn; Jane C Burns; John B Gordon
Journal:  Circulation       Date:  2012-05-17       Impact factor: 29.690

2.  Cardiac Events and the Maximum Diameter of Coronary Artery Aneurysms in Kawasaki Disease.

Authors:  Etsuko Tsuda; Nobuyuki Tsujii; Yosuke Hayama
Journal:  J Pediatr       Date:  2017-06-26       Impact factor: 4.406

3.  The 30-year outcome for patients after myocardial infarction due to coronary artery lesions caused by Kawasaki disease.

Authors:  Etsuko Tsuda; Takuya Hirata; Osamu Matsuo; Tadaaki Abe; Hisashi Sugiyama; Osamu Yamada
Journal:  Pediatr Cardiol       Date:  2010-12-01       Impact factor: 1.655

4.  Multiple Coronary Artery Bypass Grafting for Kawasaki Disease-Associated Coronary Artery Disease.

Authors:  Naoki Tadokoro; Tomoyuki Fujita; Satsuki Fukushima; Yusuke Shimahara; Yorihiko Matsumoto; Kizuku Yamashita; Naonori Kawamoto; Etsuko Tsuda; Soichiro Kitamura; Junjiro Kobayashi
Journal:  Ann Thorac Surg       Date:  2019-04-27       Impact factor: 4.330

5.  Extracoronary echocardiographic findings as predictors of coronary artery lesions in the initial phase of Kawasaki disease.

Authors:  Jean Christophe Lega; André Bozio; Rolando Cimaz; Magali Veyrier; Daniel Floret; Corinne Ducreux; Philippe Reix; Sylvie Di Filippo
Journal:  Arch Dis Child       Date:  2012-12-12       Impact factor: 3.791

Review 6.  Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association.

Authors:  Brian W McCrindle; Anne H Rowley; Jane W Newburger; Jane C Burns; Anne F Bolger; Michael Gewitz; Annette L Baker; Mary Anne Jackson; Masato Takahashi; Pinak B Shah; Tohru Kobayashi; Mei-Hwan Wu; Tsutomu T Saji; Elfriede Pahl
Journal:  Circulation       Date:  2017-03-29       Impact factor: 29.690

7.  Long-term prognosis of patients with Kawasaki disease complicated by giant coronary aneurysms: a single-institution experience.

Authors:  Kenji Suda; Motofumi Iemura; Hiroshi Nishiono; Yozo Teramachi; Yusuke Koteda; Shintaro Kishimoto; Yoshiyuki Kudo; Shinichi Itoh; Haruka Ishii; Takafumi Ueno; Tadashi Tashiro; Masakiyo Nobuyoshi; Hirohisa Kato; Toyojiro Matsuishi
Journal:  Circulation       Date:  2011-04-18       Impact factor: 29.690

8.  Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients.

Authors:  H Kato; T Sugimura; T Akagi; N Sato; K Hashino; Y Maeno; T Kazue; G Eto; R Yamakawa
Journal:  Circulation       Date:  1996-09-15       Impact factor: 29.690

9.  Myocardial infarction in Kawasaki disease: clinical analyses in 195 cases.

Authors:  H Kato; E Ichinose; T Kawasaki
Journal:  J Pediatr       Date:  1986-06       Impact factor: 4.406

10.  Twenty-five-year outcome of pediatric coronary artery bypass surgery for Kawasaki disease.

Authors:  Soichiro Kitamura; Etsuko Tsuda; Junjiro Kobayashi; Hiroyuki Nakajima; Yoshiro Yoshikawa; Toshikatsu Yagihara; Akiko Kada
Journal:  Circulation       Date:  2009-06-22       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.